Daily BriefsHealthcare

Health Care: Shanghai Medicilon Inc, Yunkang Group and more

In today’s briefing:

  • STAR50 Index Rebalance: Index Committees Just Wanna Have Fun
  • Yunkang IPO: Core Business Growth to Slow Down Post-Covid

STAR50 Index Rebalance: Index Committees Just Wanna Have Fun

By Brian Freitas

  • In keeping with tradition, the SSE and CSI have continued to use a 6 month minimum listing history. No one remembers how or why it started, but it carries on.
  • There are only 10 trading days to implementation and passive funds will need to trade multiple days of ADV on the inclusions and exclusions.
  • The adds, deletes and the SSE STAR50 (STAR50 INDEX) have moved in lockstep since November. The CSI500 Index has outperformed over the period opening up a trading opportunity.

Yunkang IPO: Core Business Growth to Slow Down Post-Covid

By Shifara Samsudeen, ACMA, CGMA

  • Yunkang Group (YK HK) is a medical operation service provider in China and offers a full suite of diagnostic testing services.
  • The company’s earnings had a boost in 2020 with the pandemic which resulted in huge demand for Covid-19 diagnostic tests.
  • Yunkang has filed for an IPO to raise about US$200m. We expect the company’s earnings to gradually decline with pandemic conditions easing off.

Before it’s here, it’s on Smartkarma